Suppr超能文献

在体外抑制大鼠腺垂体单个细胞类型的前叶垂体激素分泌过程中,大鼠腺垂体中强啡肽样免疫反应性的释放。

Release of dynorphin-like immunoreactivity from rat adenohypophysis in vitro during inhibition of anterior pituitary hormone secretion from individual cell types.

作者信息

Schwaninger M, Knepel W, Döhler K D, Sandow J

出版信息

Endocrinology. 1987 Jul;121(1):167-74. doi: 10.1210/endo-121-1-167.

Abstract

LHRH has previously been found to be the only known hypothalamic releasing factor which can specifically stimulate the release of the opioid dynorphin and other proenkephalin B-derived peptides from the rat adenohypophysis in vitro. In the present study the mechanisms that regulate dynorphin release were further characterized. It was examined whether or not dynorphin release from the adenohypophysis in vitro is altered during inhibition of the secretion of various anterior pituitary hormones. Rat anterior pituitary quarters were incubated in vitro and hormone release into the incubation medium was measured by RIAs. Somatostatin, dopamine, T3, dexamethasone, and 5 alpha-dihydrotestosterone were used to inhibit the secretion of GH, PRL, TSH, ACTH/beta-endorphin, or LH/FSH, respectively. GH, PRL, or beta-endorphin release was inhibited without affecting the simultaneous release of dynorphin A-(1-13)-like immunoreactivity (Dyn A1-13-IR). Concentrations of T3, somatostatin, or dopamine which were effective in suppressing the evoked and/or basal release of TSH, GH, or PRL, respectively, produced no effect on Dyn A1-13-IR release caused by high potassium concentration (40 mM) or LHRH (500 pM). The LHRH-induced release of LH and FSH was inhibited by the glucocorticoid dexamethasone or the androgen 5 alpha-dihydrotestosterone. Under these conditions, Dyn A1-13-IR release was also reduced. However, whereas LH release was completely blocked by 5 alpha-dihydrotestosterone, FSH and Dyn A1-13-IR release was reduced only by 50%. The release of FSH and Dyn A1-13-IR in vitro from anterior pituitary glands taken from rats, castrated 3 weeks before, was enhanced to a similar extent (about 2.5-fold); the simultaneous enhancement of LH release was significantly (P less than 0.005) greater (about 5-fold). We conclude that the mechanisms which regulate the release and/or biosynthesis of dynorphin and other proenkephalin B-derived peptides of the adenohypophysis are similar to those of the gonadotropins but different from those of any other anterior pituitary hormone, and may be more closely related with FSH release than LH release. These data support the view that dynorphin of the normal rat adenohypophysis may be localized in at least a subpopulation of gonadotrophs.

摘要

促黄体生成素释放激素(LHRH)此前已被发现是唯一已知的下丘脑释放因子,它能够在体外特异性刺激大鼠腺垂体释放阿片肽强啡肽以及其他源自脑啡肽原B的肽类。在本研究中,对调节强啡肽释放的机制进行了进一步的特征描述。研究了在抑制各种垂体前叶激素分泌的过程中,体外腺垂体释放强啡肽的情况是否会发生改变。将大鼠垂体前叶切成四分之一,进行体外孵育,并通过放射免疫分析法(RIAs)测量激素释放到孵育培养基中的量。分别使用生长抑素、多巴胺、三碘甲状腺原氨酸(T3)、地塞米松和5α-二氢睾酮来抑制生长激素(GH)、催乳素(PRL)、促甲状腺激素(TSH)、促肾上腺皮质激素/β-内啡肽(ACTH/β-endorphin)或促黄体生成素/促卵泡激素(LH/FSH)的分泌。生长激素、催乳素或β-内啡肽的释放受到抑制,而同时不影响强啡肽A-(1-13)样免疫反应性(Dyn A1-13-IR)的释放。分别有效抑制TSH、GH或PRL的诱发和/或基础释放的T3、生长抑素或多巴胺的浓度,对由高钾浓度(40 mM)或LHRH(500 pM)引起的Dyn A1-13-IR释放没有影响。糖皮质激素地塞米松或雄激素5α-二氢睾酮抑制了LHRH诱导的LH和FSH释放。在这些条件下,Dyn A1-13-IR释放也减少了。然而,虽然5α-二氢睾酮完全阻断了LH释放,但FSH和Dyn A1-13-IR释放仅减少了50%。从3周前阉割的大鼠取出的垂体前叶在体外释放FSH和Dyn A1-13-IR的量在相似程度上增加(约2.5倍);同时LH释放的增加显著(P小于0.005)更大(约5倍)。我们得出结论,调节腺垂体强啡肽和其他源自脑啡肽原B的肽类释放和/或生物合成的机制与促性腺激素的机制相似,但与任何其他垂体前叶激素的机制不同,并且可能与FSH释放的关系比与LH释放的关系更密切。这些数据支持这样一种观点,即正常大鼠腺垂体中的强啡肽可能至少定位于一部分促性腺激素细胞中。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验